Posterior distributions for parameters of interest estimated for each empirical dataset. by Leo A. Featherstone (21078333)

The real-time PCR primers sets. by Masanori A. Murayama (5774585)

Table_1_High expression of IL6 and decrease in immune cells in COVID-19 patients combined with myocardial injury.xlsx by Tingting Chen (111216)

“…Purpose<p>Myocardial injury, as a serious complication of coronavirus disease-2019 (COVID-19), increases the occurrence of adverse outcomes. …”

Table_2_High expression of IL6 and decrease in immune cells in COVID-19 patients combined with myocardial injury.xlsx by Tingting Chen (111216)

“…Purpose<p>Myocardial injury, as a serious complication of coronavirus disease-2019 (COVID-19), increases the occurrence of adverse outcomes. …”

Therapeutic administration of hMSCs failed to decrease pulmonary inflammation or modify BAL inflammatory cell counts in experimental severe influenza. by Ilyse Darwish (446378)

Therapeutic administration of mMSCs failed to decrease pulmonary inflammation or modify BAL inflammatory cell counts in experimental severe influenza. by Ilyse Darwish (446378)

Flow cytometry gating strategy. by Nathalie A. J. Verzele (18389733)

Body weight and lung immune cell population measurements following cellular ablation of lung pulmonary vagal afferents with AAVrg^{mCh FLEX DTA} in mock-infected Phox2B-Cre... by Nathalie A. J. Verzele (18389733)

Body weight, clinical score, lung pathology, lung cytokine and lung immune cell population measurements in QX-314 and vehicle treated mice following mock infection. by Nathalie A. J. Verzele (18389733)

Pharmacological inhibition of pulmonary sensory neuron activity during IAV infection and impacted lung pathology. by Nathalie A. J. Verzele (18389733)

Body weight and respiratory measurements following cellular ablation of lung pulmonary vagal afferents with AAVrg^{mCh FLEX DTA}. by Nathalie A. J. Verzele (18389733)

Body weight, lung cytokine measurements and lung immune cell populations in vagotomized and sham mice following mock infection. by Nathalie A. J. Verzele (18389733)

The impact of genetic ablation of pulmonary vagal sensory neurons on IAV pathogenesis. by Nathalie A. J. Verzele (18389733)

Serum cytokine measurements in vagotomized and sham mice following IAV infection. by Nathalie A. J. Verzele (18389733)

The impact of left vagotomy on IAV induced pathogenesis. by Nathalie A. J. Verzele (18389733)

Evidence for lack of reinnervation after cervical vagotomy and body weight measurements in mice following unilateral vagotomy or sham surgery. by Nathalie A. J. Verzele (18389733)

Characterization of AAV encoding Cre-inducible diphtheria toxin (AAVrg^{mCh FLEX DTA}) in the medullary brainstem. by Nathalie A. J. Verzele (18389733)

Primers used for vagal sensory ganglia qPCR. by Nathalie A. J. Verzele (18389733)

“…Inhibition of pulmonary vagal sensory neuron activity via inhalation of the charged sodium channel blocker, QX-314, resulted in a moderate decrease in lung pathology, but again this was accompanied by a paradoxical worsening of clinical signs. …”

The impact of right vagotomy on IAV induced pathogenesis. by Nathalie A. J. Verzele (18389733)

Comparison of IAV H1N1 viral strains. by Nathalie A. J. Verzele (18389733)